| Financial Year |
March 31 2023 |
| Monetary Funds |
5,305,622,000.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
29,253,000.00 |
| Accounts Receivable |
1,403,477,000.00 |
| Advances to Suppliers |
70,847,000.00 |
| Other Receivables |
126,741,000.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
715,000.00 |
| Dividend Receivable |
12,840,000.00 |
| Inventories |
46,427,000.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,964,102,000.00 |
| Other Current Assets |
295,322,000.00 |
| Total Current Assets |
10,447,207,000.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
9,625,043,000.00 |
| Long-term Equity Investment |
985,260,000.00 |
| Investment Properties |
-- |
| Fixed Assetes |
198,003,722,000.00 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
30,389,000.00 |
| R&D expenses |
-- |
| Goodwill |
8,772,350,000.00 |
| Long-Term Deferred and Prepaid Expenses |
18,632,000.00 |
| Deferred Income Tax Assets |
1,325,239,000.00 |
| Other Non-Current Assets |
22,858,340,000.00 |
| Sub-Total of Non-Current Assets |
245,398,479,000.00 |
| Total Assets |
255,845,686,000.00 |
| Short-Term Loans |
590,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
263,962,000.00 |
| Accounts Received In Advance |
1,556,723,000.00 |
| Employee Compensation Payable |
191,665,000.00 |
| Taxes Payable |
719,246,000.00 |
| Interest Payable |
2,060,290,000.00 |
| Dividend Payable |
-- |
| Other payables |
2,399,555,000.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
29,111,433,000.00 |
| Other Current Liabilities |
696,904,000.00 |
| Sub-Total of Current Liabilities |
35,564,018,000.00 |
| Long-term Loans |
63,490,594,000.00 |
| Bonds Payable |
99,230,493,000.00 |
| Long-Term Accounts Payable |
1,506,763,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
27,517,000.00 |
| Deferred Income Tax Liabilities |
2,231,529,000.00 |
| Other Non-Current Liabilities |
9,835,801,000.00 |
| Sub-Total of Non-Current Liabilities |
177,492,233,000.00 |
| Total Liabilities |
213,056,251,000.00 |
| Paid-In Capital(Or Share Stock) |
6,184,521,000.00 |
| Capital Surplus |
17,099,638,000.00 |
| Surplus Reserve |
239,001,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,445,442,000.00 |
| Minority Stockholder's Interest |
15,371,027,000.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
27,418,408,000.00 |
| Owner's Equity（Stockholder's Equity） |
42,789,435,000.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
255,845,686,000.00 |
